Financial Counselors Inc. Has $42.07 Million Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO)

Financial Counselors Inc. grew its stake in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 5.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 84,545 shares of the medical research company's stock after acquiring an additional 4,348 shares during the quarter. Financial Counselors Inc.'s holdings in Thermo Fisher Scientific were worth $42,070,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in TMO. Bernard Wealth Management Corp. purchased a new position in shares of Thermo Fisher Scientific in the 4th quarter worth about $25,000. Pillar Financial Advisors LLC purchased a new position in shares of Thermo Fisher Scientific in the 4th quarter worth about $29,000. Ameriflex Group Inc. purchased a new position in shares of Thermo Fisher Scientific in the 4th quarter worth about $30,000. Cassady Schiller Wealth Management LLC raised its holdings in shares of Thermo Fisher Scientific by 89.2% in the 4th quarter. Cassady Schiller Wealth Management LLC now owns 70 shares of the medical research company's stock worth $36,000 after purchasing an additional 33 shares during the period. Finally, VSM Wealth Advisory LLC purchased a new position in shares of Thermo Fisher Scientific in the 4th quarter worth about $36,000. 89.23% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms have recently commented on TMO. UBS Group downgraded Thermo Fisher Scientific from a "buy" rating to a "neutral" rating and cut their price objective for the stock from $500.00 to $460.00 in a report on Tuesday. Robert W. Baird lowered their target price on Thermo Fisher Scientific from $603.00 to $573.00 and set an "outperform" rating for the company in a research note on Thursday, April 24th. Royal Bank Of Canada lowered their target price on Thermo Fisher Scientific from $651.00 to $637.00 and set an "outperform" rating for the company in a research note on Thursday, April 24th. Evercore ISI lowered their target price on Thermo Fisher Scientific from $500.00 to $480.00 and set an "outperform" rating for the company in a research note on Tuesday. Finally, Wells Fargo & Company lowered their target price on Thermo Fisher Scientific from $580.00 to $570.00 and set an "overweight" rating for the company in a research note on Thursday, April 24th. Five analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $601.05.

Thermo Fisher Scientific Stock Performance

Shares of NYSE TMO traded up $11.56 during mid-day trading on Thursday, hitting $431.44. The company had a trading volume of 2,931,783 shares, compared to its average volume of 1,990,919. The stock has a market cap of $162.87 billion, a price-to-earnings ratio of 25.30, a PEG ratio of 2.27 and a beta of 0.77. Thermo Fisher Scientific Inc. has a 12 month low of $385.46 and a 12 month high of $627.88. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.77 and a quick ratio of 1.38. The firm's 50 day simple moving average is $408.93 and its two-hundred day simple moving average is $477.89.

Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The medical research company reported $5.15 earnings per share for the quarter, beating the consensus estimate of $5.10 by $0.05. The firm had revenue of $10.36 billion for the quarter, compared to the consensus estimate of $10.23 billion. Thermo Fisher Scientific had a return on equity of 17.15% and a net margin of 15.19%. The firm's revenue for the quarter was up .2% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.11 EPS. As a group, equities research analysts forecast that Thermo Fisher Scientific Inc. will post 23.28 earnings per share for the current year.

Thermo Fisher Scientific Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Friday, June 13th will be issued a $0.43 dividend. The ex-dividend date of this dividend is Friday, June 13th. This represents a $1.72 annualized dividend and a dividend yield of 0.40%. Thermo Fisher Scientific's dividend payout ratio (DPR) is 10.09%.

Insider Activity

In other news, EVP Gianluca Pettiti sold 300 shares of the business's stock in a transaction on Monday, April 28th. The stock was sold at an average price of $429.93, for a total transaction of $128,979.00. Following the sale, the executive vice president directly owned 23,167 shares of the company's stock, valued at $9,960,188.31. The trade was a 1.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.33% of the stock is owned by company insiders.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.